The Progentec Approach
Transformative biologic and digital technologies are needed to manage heterogeneous diseases
There are many challenges when it comes to the management of autoimmune diseases like lupus and multiple sclerosis including:
- a lack of objective disease activity measures
- the waxing and waning disease patterns
- immuno-autonomics, the complex nature between stress, fatigue, mental health, and disease activity
Progentec's innovative disease management platform combines biologic and digital biomarkers to provide clinicians unparalleled insight into a patient's health trajectory. As a result, clinicians are able to make proactive treatment decisions that improve health outcomes and reduce costs.
Lupus Technologies
aiSLE® MGMT
By combining the aiSLE® DX laboratory tests with [AutoimmuneCorner], clinicians and patients are best prepared to take on the challenges of lupus management.
aiSLE® DX Laboratory Tests
These assay-based laboratory tests are designed and validated to provide clinicians and patients with objective measures of lupus disease activity and risk.
[AutoimmuneCorner] app
Remote monitoring and sensor-driven data meets health coaching. The Sidekick Report keeps providers and patients on the same page between visits.
LupusCorner Research
Start running decentralized clinical trials with LupusCorner Research, a 21 CFR Part-11-compliant study management app that offers eConsent, validated PROs, & more.
Multiple Sclerosis Technologies
aiMS DX Laboratory Tests
Progentec is validating assay-based laboratory tests related to the prediction and measurement of MS, MS relapses, and MS classification.
More information coming soon
[AutoimmuneCorner] app
A care delivery platform and remote monitoring solution that makes it easier for clinicians and patients to work together on health initiatives.
MSCorner
Health literacy and patient community tools designed to support people living with MS and their caregivers.